Home | Cancer Discovery

The development of immune checkpoint inhibitors was a significant step forward, particularly with anti-PD-1 therapies, and brought with it impressive clinical activity in many different types of cancers, including melanoma, lung, head and neck and urothelial cancers. However, a literature review published in . … ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download